4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001493152-22-021150
Options or other derivatives
- Co- Interim CEO and CFO acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin James Joseph Co- Interim CEO and CFO | 2022-07-25 | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…